Nkarta Balance Sheet Health
Financial Health criteria checks 6/6
Nkarta has a total shareholder equity of $430.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $532.0M and $101.2M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$283.06m |
| Equity | US$430.87m |
| Total liabilities | US$101.16m |
| Total assets | US$532.03m |
Recent financial health updates
We're Hopeful That Nkarta (NASDAQ:NKTX) Will Use Its Cash Wisely
Sep 10
Here's Why We're Watching Nkarta's (NASDAQ:NKTX) Cash Burn Situation
Jan 16We're Keeping An Eye On Nkarta's (NASDAQ:NKTX) Cash Burn Rate
Oct 04We Think Nkarta (NASDAQ:NKTX) Can Afford To Drive Business Growth
Jun 21We Think Nkarta (NASDAQ:NKTX) Can Afford To Drive Business Growth
Mar 06Here's Why We're Not Too Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Situation
Nov 20Recent updates
Nkarta: Catalysts Ahead, But Competition In Cell Therapy Too (Rating Downgrade)
Oct 31We're Hopeful That Nkarta (NASDAQ:NKTX) Will Use Its Cash Wisely
Sep 10Nkarta: NK Cell Therapy Biotech With Good Standing Targeting R/R NHL Patients
Aug 14Nkarta: A Look Into Q1 Results And Upcoming Catalysts
May 23Nkarta: Down 50% Since March With A Clinical Catalyst Ahead
Apr 27Nkarta: NK Cell Therapy Advancement On Two Fronts
Mar 25Nkarta: Possible Upside From H1 Update, If Positive
Jan 25Here's Why We're Watching Nkarta's (NASDAQ:NKTX) Cash Burn Situation
Jan 16We're Keeping An Eye On Nkarta's (NASDAQ:NKTX) Cash Burn Rate
Oct 04We Think Nkarta (NASDAQ:NKTX) Can Afford To Drive Business Growth
Jun 21We Think Nkarta (NASDAQ:NKTX) Can Afford To Drive Business Growth
Mar 06Here's Why We're Not Too Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Situation
Nov 20Nkarta GAAP EPS of -$0.61
Aug 11We're Not Very Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Rate
Jun 09Nkarta: A Promising Natural Killer Cell Play
May 20We Think Nkarta (NASDAQ:NKTX) Can Afford To Drive Business Growth
Aug 23Nkarta (NASDAQ:NKTX) Is In A Good Position To Deliver On Growth Plans
May 10Nkarta gets greenlight from the FDA for NKX019 cancer study
Apr 28We're Not Very Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Rate
Jan 25
Financial Position Analysis
Short Term Liabilities: NKTX's short term assets ($290.2M) exceed its short term liabilities ($22.5M).
Long Term Liabilities: NKTX's short term assets ($290.2M) exceed its long term liabilities ($78.7M).
Debt to Equity History and Analysis
Debt Level: NKTX is debt free.
Reducing Debt: NKTX has no debt compared to 5 years ago when its debt to equity ratio was 19.8%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NKTX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: NKTX has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of 28.5% each year.